A Phase IIIB, Multi-center, Open Label Follow-up Study to Evaluate the Safety and Efficacy of Certolizumab Pegol Administered Concomitantly With DMARDs in Patients With Active Rheumatoid Arthritis Who Participated in C87076.
收藏DataCite Commons2025-03-04 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00007915/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
To continue to assess the clinical safety and efficacy of Certolizumab Pegol as add-on
therapy with stable-dose Disease Modifying Anti-Rheumatic Drugs (DMARDs)
提供机构：
Vivli
创建时间：
2022-06-17
